Form 8-K - Current report:
SEC Accession No. 0000950170-25-078341
Filing Date
2025-05-28
Accepted
2025-05-28 16:15:08
Documents
10
Period of Report
2025-05-21
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K rapt-20250521.htm   iXBRL 8-K 44096
  Complete submission text file 0000950170-25-078341.txt   150364

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT rapt-20250521.xsd EX-101.SCH 25013
12 EXTRACTED XBRL INSTANCE DOCUMENT rapt-20250521_htm.xml XML 4752
Mailing Address 561 ECCLES AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 561 ECCLES AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 489-9000
RAPT Therapeutics, Inc. (Filer) CIK: 0001673772 (see all company filings)

EIN.: 473313701 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38997 | Film No.: 25995575
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)